Excessive DKK1 production could indirectly establish a tumor niche, resulting in AML progression, while suppression of DKK1 by exogenous agents delayed AML progression and prolonged survival in animal models [36]. The gene discussed is DKK1; the disease is acute myeloid leukemia.